These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6756907)

  • 1. Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.
    Grüneberg RN; Emmerson AM
    Eur J Clin Microbiol; 1982 Jun; 1(3):155-8. PubMed ID: 6756907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro resistance of canine staphylococci to trimethoprim and sulphamethoxazole alone and in combination.
    Hinton M; Marston M; Crisfield J
    J Vet Pharmacol Ther; 1981 Mar; 4(1):33-8. PubMed ID: 6984087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological perspectives of co-trimoxazole.
    Bauernfeind A; Hörl G; Przyklenk B
    Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.
    Nakhla LS
    J Clin Pathol; 1972 Aug; 25(8):708-12. PubMed ID: 5076806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
    Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S
    Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of non-epidemic Shigella sonnei resistant to co-trimoxazole.
    Palenque E; Otero JR; Noriega AR
    J Antimicrob Chemother; 1983 Feb; 11(2):196-8. PubMed ID: 6339462
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.
    Toivanen A; Kasan A; Sundquist H; Toivanen P
    Chemotherapy; 1976; 22(2):97-103. PubMed ID: 1253636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function.
    Emmanouilides CE; Lianou PE; Bassaris HP; Papavassiliou JT
    J Antimicrob Chemother; 1990 Dec; 26(6):803-12. PubMed ID: 2081720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin, sulphamethoxazole, and trimethoprim in synergy against Gram-negative bacteria.
    Simmons NA
    J Clin Pathol; 1970 Dec; 23(9):757-64. PubMed ID: 4994097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro sensitivity of Bordetella pertussis.
    Zackrisson G; Brorson JE; Krantz I; Trollfors B
    J Antimicrob Chemother; 1983 May; 11(5):407-11. PubMed ID: 6307963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.